CD68 and nasopharyngeal carcinoma: Furthermore, we found that genetic ablation of C3 in a Npc1−/− mouse background reduces the presence of hepatic CD68 positive cells at postnatal day 56 and prevents the increase of transaminases blood levels in NPC mice.